ACH · Accendra Health Inc/Va/
$0.95
-0.15 (-13.55%)
At close · Aug 14
Market Cap
$78.44M
Shares
76.90M
Accendra Health Inc Earnings Call Transcripts
Every quarterly earnings call for Accendra Health Inc (ACH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼0.2%
$2.50B
$12.50M
'22 Q3
22-11-02
▲3.4%
$2.55B
−$57.99M
'22 Q4
23-02-28
▲4.8%
$2.52B
−$24.42M
'23 Q1
23-05-05
▲2.5%
$2.56B
−$28.24M
'23 Q2
23-08-04
▲3.8%
$2.59B
−$6.43M
'23 Q3
23-11-03
▼300.9%
$
$17.78M
'23 Q4
24-02-20
▲3.6%
$2.61B
−$21.89M
'24 Q1
24-05-03
▼74.2%
$660.40M
−$31.91M
'24 Q2
24-08-02
▼73.5%
$686.85M
−$12.77M
'24 Q3
24-11-04
·
$
−$296.12M
'24 Q4
25-02-28
▼74.2%
$673.88M
−$24.98M
'25 Q1
25-05-08
▲3.3%
$681.92M
−$869.06M
'25 Q2
25-08-11
▲1.5%
$697.26M
−$150.28M
'25 Q3
25-10-30
·
$708.97M
−$56.33M
'25 Q4
26-02-19
▼6.8%
$627.78M
−$6.47M
'26 Q1
26-05-11
LATEST
▼10.1%
$613.23M
−$89.07M
'26 Q2
26-08-10
Earnings call
FY26 · Q2
2026-08-10
Accendra Health Inc/Va/ Q2 FY2026 Earnings Call
Positive tone
Cost reduction and efficiency initiatives
CEO retirement and leadership transition
Sleep center of excellence rollout
Revenue
$613.23M
▼ 10.1% YoY Diluted EPS
$-1.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-11
Accendra Health Inc/Va/ Q1 FY2026 Earnings Call
Confident tone
Large commercial payor exit
Sleep therapy growth initiatives
Commercial payor portfolio and renewals
Revenue
$627.78M
▼ 6.8% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-19
Accendra Health Inc/Va/ Q4 FY2025 Earnings Call
Confident tone
Loss of large commercial payer and stranded costs
Capital structure and debt reduction
Home-based care market opportunity
Revenue
$708.97M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Accendra Health Inc/Va/ Q3 FY2025 Earnings Call
Confident tone
Loss of large customer (Kaiser) contract
Patient Direct home-based care strategy
Optum preferred provider agreement
Revenue
$697.26M
▲ 1.5% YoY Diluted EPS
$-1.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Accendra Health Inc/Va/ Q2 FY2025 Earnings Call
Positive tone
Patient Direct strategic focus and divestiture of P&HS
Q2 financial results and revenue growth
Stranded costs and post-divestiture cost structure
Revenue
$681.92M
▲ 3.3% YoY Diluted EPS
$-11.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Accendra Health Inc/Va/ Q1 FY2025 Earnings Call
Positive tone
Patient Direct segment performance
Rotech acquisition
Medical Distribution and proprietary products
Revenue
$673.88M
▼ 74.2% YoY Diluted EPS
$-0.32
Gross margin
78.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-28
Accendra Health Inc/Va/ Q4 FY2024 Earnings Call
Positive tone
Patient Direct segment performance and growth
Rotech acquisition and regulatory clearance
Share repurchase program
Revenue
$*
Gross margin
-45.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Accendra Health Inc/Va/ Q3 FY2024 Earnings Call
Confident tone
Patient Direct growth in sleep and diabetes
Rotech acquisition
Products and Healthcare Services segment performance
Revenue
$686.85M
▼ 73.5% YoY Diluted EPS
$-0.16
Gross margin
81.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-02
Accendra Health Inc/Va/ Q2 FY2024 Earnings Call
Confident tone
Patient Direct Segment Growth
Cash Flow and Working Capital
Products & Healthcare Services Segment Performance
Revenue
$660.40M
▼ 74.2% YoY Diluted EPS
$-0.42
Gross margin
82.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Accendra Health Inc/Va/ Q1 FY2024 Earnings Call
Positive tone
Patient Direct segment performance and reimbursement
Free cash flow and balance sheet
Gross margin expansion
Revenue
$2.61B
▲ 3.6% YoY Diluted EPS
$-0.29
Gross margin
20.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Accendra Health Inc/Va/ Q4 FY2023 Earnings Call
Confident tone
Patient Direct segment growth
2024 financial guidance
LIFO and stock comp normalization in adjusted EBITDA
Revenue
$*
▼ 300.9% YoY Gross margin
-11.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Accendra Health Inc/Va/ Q3 FY2023 Earnings Call
Revenue
$2.59B
▲ 3.8% YoY Diluted EPS
$-0.08
▼ 150% YoY Gross margin
20.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-04
Accendra Health Inc/Va/ Q2 FY2023 Earnings Call
Revenue
$2.56B
▲ 2.5% YoY Diluted EPS
$-0.37
▼ 200% YoY Gross margin
20.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
Accendra Health Inc/Va/ Q1 FY2023 Earnings Call
Revenue
$2.52B
▲ 4.8% YoY Diluted EPS
$-0.32
▼ 161.5% YoY Gross margin
19.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Accendra Health Inc/Va/ Q4 FY2022 Earnings Call
Revenue
$2.55B*
▲ 3.4% YoY Gross margin
16.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Accendra Health Inc/Va/ Q3 FY2022 Earnings Call
Revenue
$2.50B
▼ 0.2% YoY Diluted EPS
$0.16
▼ 72.4% YoY Gross margin
20.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Accendra Health Inc/Va/ Q2 FY2022 Earnings Call
Revenue
$2.50B
▲ 0.4% YoY Diluted EPS
$0.37
▼ 57.5% YoY Gross margin
21.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Accendra Health Inc/Va/ Q1 FY2022 Earnings Call
Revenue
$2.41B
▲ 3.5% YoY Diluted EPS
$0.52
▼ 46.9% YoY Gross margin
15.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Accendra Health Inc/Va/ Q4 FY2021 Earnings Call
Revenue
$2.47B*
▲ 4.5% YoY Gross margin
13.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Accendra Health Inc/Va/ Q3 FY2021 Earnings Call
Revenue
$2.50B
▲ 14.4% YoY Diluted EPS
$0.58
▼ 23.7% YoY Gross margin
13.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Accendra Health Inc/Va/ Q2 FY2021 Earnings Call
Revenue
$2.49B
▲ 37.7% YoY Diluted EPS
$0.87
Gross margin
16.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Accendra Health Inc/Va/ Q1 FY2021 Earnings Call
Revenue
$2.33B
▲ 9.6% YoY Diluted EPS
$0.98
Gross margin
19.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Accendra Health Inc/Va/ Q4 FY2020 Earnings Call
Revenue
$2.36B*
▲ 7.8% YoY Gross margin
16.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Accendra Health Inc/Va/ Q3 FY2020 Earnings Call
Revenue
$2.19B
▼ 4.6% YoY Diluted EPS
$0.76
Gross margin
15.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-09-24
Accendra Health Inc/Va/ Q2 FY2020 Earnings Call
Revenue
$1.81B
▼ 23.9% YoY Diluted EPS
$-0.91
Gross margin
14.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Accendra Health Inc/Va/ Q1 FY2020 Earnings Call
Revenue
$2.12B
▼ 9.7% YoY Gross margin
12.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-04
Accendra Health Inc/Va/ Q4 FY2019 Earnings Call
Revenue
$2.19B*
▲ 3.2% YoY Gross margin
13.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
75252
CUSIP
690732102
13F (30d)
133 filings
132 filers
Visit website
Investor relations